Emulate is a private company that is commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for simulating true human physiology so that responses to medicines, chemicals, and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design, and safety across a range of applications in drug development, personalized medicine, agriculture, and chemical-based consumer products.